Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teladoc Health Inc (NY: TDOC )

7.120 +0.330 (+4.86%)
Streaming Delayed Price Updated: 1:42 PM EDT, Aug 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Teladoc Health Inc

< Previous 1 2 3 4 5 6 7 Next >
Teladoc Health Reports Fourth Quarter and Full Year 2023 Results
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health Provides Updated Start Time for Fourth Quarter 2023 Earnings Call on February 20, 2024
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health to Announce Fourth Quarter 2023 Financial Results
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health highlights progress in advancing care access, sustainability in new report
Industry leader releases fourth annual Corporate Social Responsibly (CSR) report 
From Teladoc Health, Inc.
Via GlobeNewswire
Weight Watchers gains from Oprah’s GLP-1 weight-loss
Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Teladoc Health to Participate in Upcoming Investor Conference
From Teladoc Health, Inc.
Via GlobeNewswire
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing 
Via MarketBeat
3 more tax-loss selling buy opportunities
This is the season when tax-loss selling occurs; here are three tax-loss selling buy opportunities for risk-tolerant investors and speculators to consider 
Via MarketBeat
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
From Teladoc Health, Inc.
Via GlobeNewswire
Ozempic vs. Mounjaro:: Battle of the bulge
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage 
Via MarketBeat
Exposures Product Safety
Teladoc Health to Participate in Upcoming Investor Conference
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health Reports Third Quarter 2023 Results
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health to Announce Third Quarter 2023 Financial Results
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors
From Teladoc Health, Inc.
Via GlobeNewswire
77% of Employers Plan to Increase Investment in Virtual Health Care, says Teladoc Health’s 2023 Virtual Care Transformation Index
Findings from annual study also reinforce the value of whole-person care, equitable access and a balanced approach to GLP-1s & weight management for employers 
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health Is Providing Free Virtual Health Care Services to Florida Residents Impacted by Hurricane Idalia
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health Is Providing Free Virtual Health Care Services to Hawaii Residents Impacted by Wildfires
From Teladoc Health, Inc.
Via GlobeNewswire
MarketBeat Week in Review – 07/31 - 08/04
A weaker than expected jobs report lifted the market but next week's CPI and PPI reports could change investor sentiment 
Via MarketBeat
Topics Economy
Exposures Interest Rates
The Recovery in Teladoc is Showing Signs of Life
The world’s largest virtual healthcare services provider Teladoc Health Inc. (NYSE: TDOC) stock is finally breaking out of its year-long bearish weekly descend 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Teladoc Health Inc. (NYSE: TDOC) Near Top of Volume Charts in Wednesday Trading
Via Investor Brand Network
Teladoc Health Reports Second Quarter 2023 Results
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health Expands Collaboration in AI with Microsoft to Address Healthcare Workforce Crisis
Strategic efforts will help minimize administrative burden by automating clinical documentation during virtual and in-patient care 
From Teladoc Health, Inc.
Via GlobeNewswire
Teladoc Health to Announce Second Quarter 2023 Financial Results
From Teladoc Health, Inc.
Via GlobeNewswire
INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates Teladoc Health, Inc.’s Directors and Officers for Breach of Fiduciary Duties – TDOC
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Doximity is an Overlooked Medical Ecosystem AI Play
Doximity Inc. (NASDAQ: DOCS) is a digital professional social network platform for medical practitioners. It’s a medical community networking platform like 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
How to Invest in Telehealth and Telemedicine Stocks
Investing in telehealth and telemedicine may boost your portfolio. Learn how to invest in telehealth and telemedicine stocks. 
Via MarketBeat
Exposures COVID-19
The Turnaround for Weight Watchers is Taking Shape
Weight management meals and services provider WW International Inc. (NYSE: WW) stock made a 52-week high of $10.02 after its Q1 2023 earnings release. Shares 
Via MarketBeat
MarketBeat Week in Review – 5/1 - 5/5
A strong jobs report, Apple earnings, and a possible Fed pause were stories moving the market this week. Here are some of the other popular stories this week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Can Teladoc Stock Be Resuscitated?
Virtual healthcare services company Teladoc Health Inc. (NYSE: TDOC) has had a treacherous journey rising to a high of $308 in Feb 2021 and falling to a post- 
Via MarketBeat
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.